USFDA red flags GPT Pharmaceuticals for significant violations at Hyderabad unit

The inspection was conducted from June 24 to 28, 2019.

 
– The Hindu – Industry

• Share on Facebook
• Tweet it
• Pin it
• Share it
• Email